PhysiomicsÂ’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.
| COO: |
Jesse Thissen |
| Executive Chairman: |
James Simon Millen |
| Executive Director: |
Ian Bagnall |
| Independent Non-Executive Director: |
Timothy (Tim) Corn, Shalabh Kumar |
| Address: |
Milton Park Innovation Centre, 99 Park Drive, Milton Park, Oxfordshire, United Kingdom |
| Phone: |
+44 (0) 1235 841575 |
| Fax: |
|
| Website: |
http://www.physiomics.co.uk/ |
| Email: |
|